Kelly Lawrence W & Associates’s Organon & Co OGN Stock Holding History

Kelly Lawrence W & Associates’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,383	Closed	-$174K	–	166
2023 Q1	$174K	Hold	7,383	–	–	0.05%	75
2022 Q4	$206K	Sell	7,383 -1,905	-21%	-$48.7K	0.06%	70
2022 Q3	$218K	Sell	9,288 -122	-1%	-$3.68K	0.06%	81
2022 Q2	$318K	Hold	9,410	–	–	0.09%	72
2022 Q1	$329K	Sell	9,410 -112	-1%	-$3.83K	0.07%	62
2021 Q4	$290K	Sell	9,522 -453	-5%	-$14.8K	0.06%	64
2021 Q3	$327K	Sell	9,975 -657	-6%	-$21K	0.07%	64
2021 Q2	$322K	Buy	+10,632	New	+$350K	0.07%	66

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Kelly Lawrence W & Associates's OGN Position: Q2 2023 in Review

Kelly Lawrence W & Associates sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 7,383 shares — an estimated $174K sold.

Kelly Lawrence W & Associates first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $329K in Q1 2022. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

Kelly Lawrence W & Associates reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
Kelly Lawrence W & Associates sold 7,383 Organon & Co shares in Q2 2023, an estimated $174K.
Kelly Lawrence W & Associates first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
Kelly Lawrence W & Associates's Organon & Co position peaked at $329K in Q1 2022.
726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2023, filed 14 Aug 2023.